|
[1]
|
赵勤, 李建飞, 杨进, 张林潮, 漆洁, 韦金儒. 老年人骨密度、骨代谢相关内分泌激素与冠状动脉钙化的相关性研究[J]. 医学临床研究, 2012, 29(9): 1636-1639.
|
|
[2]
|
Ye, C., Xu, M., Wang, S., Jiang, S., Chen, X., Zhou, X., et al. (2016) Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis. PLOS ONE, 11, e0154740. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Manubolu, V.S., Mao, S., Kinninger, A., Dahal, S., Ahmad, K., Havistin, R., et al. (2023) Association between Coronary Artery Calcium and Thoracic Spine Bone Mineral Density: Multiethnic Study of Atherosclerosis (MESA). Nutrition, Metabolism and Cardiovascular Diseases, 33, 532-540. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Farhat, G.N., Cauley, J.A., Matthews, K.A., Newman, A.B., Johnston, J., Mackey, R., et al. (2006) Volumetric BMD and Vascular Calcification in Middle-Aged Women: The Study of Women's Health across the Nation. Journal of Bone and Mineral Research, 21, 1839-1846. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hyder, J.A., Allison, M.A., Wong, N., Papa, A., Lang, T.F., Sirlin, C., et al. (2009) Association of Coronary Artery and Aortic Calcium with Lumbar Bone Density: The MESA Abdominal Aortic Calcium Study. American Journal of Epidemiology, 169, 186-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zeng, X., Wang, D., Yang, H., Liu, Z., Li, X., Xiong, T., et al. (2026) Association between Bone Mineral Density and Coronary Artery Calcification: An Updated Systematic Review and Meta-Analysis. BMC Cardiovascular Disorders, 26, Article No. 317. [Google Scholar] [CrossRef]
|
|
[7]
|
Shen, Y. and Yu, C. (2024) The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification. Kidney Diseases, 10, 545-557. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Han, T., Qu, Y., Zhu, J., Sha, L., Lei, B., Xiang, R., et al. (2026) A Comprehensive Multi-Layered Analysis Reveals Genetic Pleiotropy Underlying Coronary Artery Calcification and Bone Mineral Density. Bone, 203, Article ID: 117719. [Google Scholar] [CrossRef]
|
|
[9]
|
杨莹, 杨虹, 李玲玲, 等. 骨质疏松与冠状动脉钙化相关机制研究进展[J]. 兰州大学学报(医学版), 2023, 49(4): 76-82.
|
|
[10]
|
赵圆, 邢艳, 刘文亚, 等. 基于定量CT对绝经后无症状冠心病患者腰椎骨密度与冠脉钙化的相关研究[J]. 中国骨质疏松杂志, 2011, 17(12): 1068-1072.
|
|
[11]
|
耿广. 骨和肌肉定量CT指标与冠心病严重程度相关性的研究[D]: [博士学位论文]. 石家庄: 河北医科大学, 2025.
|
|
[12]
|
Kim, K.M., Yoon, Y.E., Yun, B.L. and Suh, J. (2022) Association between Bone Mineral Density and Coronary Atherosclerotic Plaque According to Plaque Composition: Registry for the Women Health Cohort for Bone, Breast, and Coronary Artery Disease Study. Journal of Bone Metabolism, 29, 123-131. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ismaili, J., Poniku, A., Berisha-Muharremi, V., Batalli, A., Tafarshiku, R., Henein, M.Y., et al. (2025) Decreased Bone Mineral Density Is Associated with Subclinical Atherosclerosis in Asymptomatic Non-Diabetic Postmenopausal Women. Journal of Clinical Medicine, 14, Article No. 4033. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Yang, Y., Li, L., Zhang, Y., Yang, H., Bai, J., Lv, H., et al. (2022) Association between Coronary Artery Calcium Score and Bone Mineral Density in Type 2 Diabetes Mellitus with Different Visceral Fat Area. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 3949-3960. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kim, H., Lee, J., Lee, K., Kim, Y., Hong, N., Park, J.T., et al. (2021) Low Bone Mineral Density Is Associated with Coronary Arterial Calcification Progression and Incident Cardiovascular Events in Patients with Chronic Kidney Disease. Clinical Kidney Journal, 15, 119-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Palm, V., Wagner, A., Havlicek, O., Sedaghat, S., Nauck, S., von Stackelberg, O., et al. (2026) Exploring the Bone-Vascular Axis: AI-Augmented Chest CT Analysis in COPD Highlights Association between Vertebral Bone Density and Arterial Calcifications. Respiratory Medicine, 258, Article ID: 108888. [Google Scholar] [CrossRef]
|
|
[17]
|
刘梦苑, 郎欣月, 杨进刚, 等. 骨质疏松症与冠状动脉钙化相关性的Meta分析[J]. 中国循环杂志, 2022, 37(8): 810-816.
|
|
[18]
|
Lee, D.H., Youn, H., Yi, J.E., Chin, J.Y., Kim, T., Jung, H., et al. (2013) Gender Difference in Bone Loss and Vascular Calcification Associated with Age. Korean Circulation Journal, 43, 453-461. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Luo, J., Wang, Q., Liu, W., Liao, H., Qing, W., Zhang, M., et al. (2025) Computed Tomography Provides a “One-Stop-Shop” Targeted Analysis for Coronary Artery Calcification and Osteoporosis: A Review. Frontiers in Endocrinology (Lausanne), 16, Article ID: 1356831. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
安娜, 张明健, 牛利, 等. 2型糖尿病患者冠状动脉钙化与骨代谢指标的相关性研究[J]. 中国骨质疏松杂志, 2023, 29(8): 1141-1146.
|
|
[21]
|
李娜, 张娟娟, 付智鹏. 老年冠心病患者冠状动脉钙化评分与骨密度及FRAX的关系[J]. 江苏医药, 2021, 47(3): 260-263.
|
|
[22]
|
Lu, H., Lary, C.W., Hodonsky, C.J., Peyser, P.A., Bos, D., van der Laan, S.W., et al. (2024) Association between BMD and Coronary Artery Calcification: An Observational and Mendelian Randomization Study. Journal of Bone and Mineral Research, 39, 443-452. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Malluche, H.H., Blomquist, G., Monier-Faugere, M., Cantor, T.L. and Davenport, D.L. (2015) High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis. Journal of the American Society of Nephrology, 26, 2534-2544. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Waitupu, A., Pratiwi, L., Sutanto, H., et al. (2025) Molecular Pathophysiology of Chronic Kidney Disease-Mineral and Bone Disorder: Focus on the Fibroblast Growth Factor 23-Klotho Axis and Bone Turnover Dynamics. Experimental Physiology, 1-13.
|
|
[25]
|
Pendón-Ruiz de Mier, M.V., Santamaría, R., Moyano-Peregrín, C., Gordillo, J.E., Salmoral-Chamizo, A., López-López, I., et al. (2024) Bone and Vascular Effects of Magnesium Supplements in CKD Patients (the Magicalbone Pilot Study). Nefrología (English Edition), 44, 721-730. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Cannata-Andía, J.B., Carrillo-López, N., Messina, O.D., Hamdy, N.A.T., Panizo, S. and Ferrari, S.L. (2021) Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing? Nutrients, 13, Article No. 3835. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Bucay, N., Sarosi, I., Dunstan, C.R., Morony, S., Tarpley, J., Capparelli, C., et al. (1998) Osteoprotegerin-Deficient Mice Develop Early Onset Osteoporosis and Arterial Calcification. Genes & Development, 12, 1260-1268. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhang, L., Zeng, F., Jiang, M., Han, M. and Huang, B. (2022) Roles of Osteoprotegerin in Endocrine and Metabolic Disorders through Receptor Activator of Nuclear Factor Kappa-B Ligand/Receptor Activator of Nuclear Factor Kappa-B Signaling. Frontiers in Cell and Developmental Biology, 10, Article ID: 1005681. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Samelson, E.J., Miller, P.D., Christiansen, C., Daizadeh, N.S., Grazette, L., Anthony, M.S., et al. (2014) RANKL Inhibition with Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women with Osteoporosis and High Cardiovascular Risk. Journal of Bone and Mineral Research, 29, 450-457. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Register, T.C., Hruska, K.A., Divers, J., Bowden, D.W., Palmer, N.D., Carr, J.J., et al. (2014) Sclerostin Is Positively Associated with Bone Mineral Density in Men and Women and Negatively Associated with Carotid Calcified Atherosclerotic Plaque in Men from the African American-Diabetes Heart Study. The Journal of Clinical Endocrinology & Metabolism, 99, 315-321. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Lin, Y., Jiang, P., Lv, Y. and Tian, W. (2026) Postmenopausal Osteoporosis and Vascular Calcification: The Estrogen Regulation Network and Calcification Paradox. Journal of Translational Internal Medicine, 14, 192-203. [Google Scholar] [CrossRef]
|
|
[32]
|
Weng, S., Ding, C., Shi, Y., Zhang, H., Zhao, W., Zhu, J., et al. (2026) Osteoporosis Therapies and Coronary Risk: Insights from Vascular Calcification Biology and Sclerostin Signaling. Frontiers in Endocrinology, 17, Article ID: 1839111. [Google Scholar] [CrossRef]
|
|
[33]
|
Zhang, N., Wang, L., Li, X., Yang, X., Tao, X., Jiang, H., et al. (2025) Role of Sclerostin in Cardiovascular System. International Journal of Molecular Sciences, 26, Article No. 4552. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Ferrières, L., Laroche, M., Degboé, Y., Jaafar, A. and Ferrières, J. (2025) The Serum Levels of FGF23, Sclerostin, Osteoprotegerin Do Not Explain the Inverse Relationship between Coronary Calcifications and Bone Mineral Density Evaluated Using Computed Tomography. Frontiers in Cardiovascular Medicine, 12, Article ID: 1583124. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
卢维晟, 张江蓉, 高艳虹, 等. 血清骨钙素水平与老年骨质疏松及冠状动脉病变的相关性[J]. 中国医药, 2013, 8(11): 1612-1614.
|
|
[36]
|
Wei, X., Huang, X., Liu, N., Qi, B., Fang, S. and Zhang, Y. (2021) Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho Axis. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 7536614. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Mattinzoli, D., Rastaldi, M.P., Ikehata, M., Armelloni, S., Pignatari, C., Giardino, L.A., et al. (2016) FGF23-Regulated Production of Fetuin-A (AHSG) in Osteocytes. Bone, 83, 35-47. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wungu, C.D.K., Susilo, H., Alsagaff, M.Y., Witarto, B.S., Witarto, A.P., Pakpahan, C., et al. (2024) Role of Klotho and Fibroblast Growth Factor 23 in Arterial Calcification, Thickness, and Stiffness: A Meta-Analysis of Observational Studies. Scientific Reports, 14, Article No. 5712. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Wicik, Z., Jales Neto, L.H., Guzman, L.E.F., Pavão, R., Takayama, L., Caparbo, V.F., et al. (2021) The Crosstalk between Bone Metabolism, lncRNAs, microRNAs and mRNAs in Coronary Artery Calcification. Genomics, 113, 503-513. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
He, L., Xu, J., Bai, Y., Zhang, H., Zhou, W., Cheng, M., et al. (2021) MicroRNA-103a Regulates the Calcification of Vascular Smooth Muscle Cells by Targeting Runt-Related Transcription Factor 2 in High Phosphorus Conditions. Experimental and Therapeutic Medicine, 22, Article No. 1036. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Wang, S., Wang, C. and Chen, H. (2020) MicroRNAs Are Critical in Regulating Smooth Muscle Cell Mineralization and Apoptosis during Vascular Calcification. Journal of Cellular and Molecular Medicine, 24, 13564-13572. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Palamar, M., Grosu Radulescu, I.D., Tanasescu, M.D., Sircuta, A. and Bob, F. (2025) Vascular Calcification in Chronic Kidney Disease and Hemodialysis: Pathophysiological Mechanisms and Emerging Biomarkers. Medicina (Kaunas), 61, Article No. 2169. [Google Scholar] [CrossRef]
|
|
[43]
|
Ghosh, M., Khanam, R., Sengupta, A. and Chakraborty, S. (2024) Oxidative-Stress Induced Bmp2-Smad1/5/8 Signaling Dependent Differentiation of Early Cardiomyocytes from Embryonic and Adult Epicardial Cells. Differentiation, 136, Article ID: 100756. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Mou, K., Chan, S.M.H. and Vlahos, R. (2024) Musculoskeletal Crosstalk in Chronic Obstructive Pulmonary Disease and Comorbidities: Emerging Roles and Therapeutic Potentials. Pharmacology & Therapeutics, 257, Article ID: 108635. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Revel, M.P., Goo, J.M., Vliegenthart, R., et al. (2026) Smoking-Related Comorbidities Detected through Low-Dose CT Imaging Lung Cancer Screening: Current Evidence and Future Directions. Chest, 169, 1457-1458.
|
|
[46]
|
Iavrumov, E., Cravcenco, D., Ceasovschih, A., Sivapalan, P., Siafakas, N. and Corlateanu, A. (2026) Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT). Journal of Clinical Medicine, 15, Article No. 785. [Google Scholar] [CrossRef]
|
|
[47]
|
Cortiana, V., Vaghela, H., Bakhle, R., Santhosh, T., Kaiwan, O., Tausif, A., et al. (2024) Beyond the Heart: The Predictive Role of Coronary Artery Calcium Scoring in Non-Cardiovascular Disease Risk Stratification. Diagnostics (Basel), 14, Article No. 2349. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
王倩. 2型糖尿病椎体骨密度与冠状动脉钙化的DECT定量研究[D]: [硕士学位论文]. 衡阳: 南华大学, 2024.
|
|
[49]
|
Guzman, L.F.E., Lopes, N.H.M., Torres, G.H.F., Takayama, L., de Sousa Andrade, S., Lanz-Luces, J.R., et al. (2022) Coronary Calcification and Bone Microarchitecture by High-Resolution Peripheral Quantitative Computed Tomography from the São Paulo Ageing and Health (SPAH) Study. Scientific Reports, 12, Article No. 5282. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Naghavi, M., De Oliveira, I., Mao, S.S., Jaberzadeh, A., Montoya, J., Zhang, C., et al. (2023) Opportunistic AI-Enabled Automated Bone Mineral Density Measurements in Lung Cancer Screening and Coronary Calcium Scoring CT Scans Are Equivalent. European Journal of Radiology Open, 10, Article ID: 100492. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Geers, J., Bing, R., Pawade, T.A., Doris, M.K., Daghem, M., Fletcher, A.J., et al. (2024) Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial. Journal of the American Heart Association, 13, e032571. [Google Scholar] [CrossRef] [PubMed]
|